Specialist investor August Equity has made a new acquisition from its Partners III fund and added a social care business to its portfolio.
US-based investor Albion Ventures has expanded its SaaS portfolio by backing healthcare offering Cisiv.
Baird Capital portfolio company MedPlast has snapped up UK-based Orthoplastics for an undisclosed amount.
Scottish Equity Partners has closed its second deal in a week by investing in Aridhia Informatics alongside fellow VC Albion Ventures.
A new technology aimed improving the speed of surgical procedures has closed the first stage of a £2.5 million funding round.
A Series B venture capital financing round worth £15 million has been led by Fidelity Biosciences and Novo A/S.
Molecular diagnostics business Biofortuna has closed another round of venture capital funding so that it can target the US market.
The steady income streams and low risk profiles of pharmacy businesses are proving increasingly attractive for private equity investors, new figures suggest.
An eight-year involvement with dental membership plan business Practice Plan has netted Dunedin Private Equity a 2.8x return on its investment.
Science in Sport is targeting its share of a reported £19.6 billion global market in 2010 by securing a stock market listing.
Private equity firm Graphite Capital has followed up on its recent investment in the Hawksmoor chain of restaurants by exiting its interest in Willowbrook Healthcare.
The Biomedical Catalyst is allocating £25.9 million as part of a new support package for businesses and academic projects in the health industry.
The Seed Enterprise Investment Scheme (SEIS) has allowed biotechnology business Oxford Genetics to net £150,000 of new funding.
The North West Fund for Biomedical and Fusion IP are coming together to back the growth ambition of University of Sheffield spin-out Absynth Biologics.
A £250,000 investment led North West Fund for Biomedical will be used by Tomorrows Medicines to commercialise its new platform.
Private equity firm ECI Partners has sold its stake in CliniSys and netted a 2.5x return on its 2007 investment.
Venture capital firm Atomico has stepped up to lead a $10 million investment into ChemistDirect.
AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.
A thirty one-year old specialist furniture business has taken on private equity backing as it looks to grow through organic and acquisitive means.
The £25 million North West Fund for Biomedical has made its 57th investment to date through the backing of Perfectus Biomed.
At a time when pay-as-you-go and disposable phones were all the rage, Jo Wimble-Groves realised that a one-size-fits-all approach would undercut a huge chunk of business technology users. In 1996, she set up Active Digital to provide businesses with the mobile technology they actually need, and since then, has worked with clients as varied as GB Taekwondo and Iron Maiden
A short term loan can keep you in the black, especially if you're dealing with late payments or are still in the process of establishing a solid credit history
With one company threatening dismissal if the game is played in work and Boeing finding it had been downloaded 100 times on company mobiles, Law at Work’s legal adviser Paman Singh reflects on whether employers should be considering a Pokémon policy
The annual Directors’ Pay on AIM report is the most comprehensive review of directors’ remuneration on AIM available. It’s ideal for benchmarking your team’s salary, that of your organisation and even your own salary.